Overview
The main goals of this study are:
- To learn what happens to one dose of MK-2828 in a healthy person's body over time when it is taken with itraconzole
- To learn what happens to one dose of midazolam in a healthy person's body over time when it is taken with MK-2828
Researchers want to learn if the levels of MK-2828 in the body are about the same when MK-2828 is taken with itraconazole as when it is taken alone. They also want to know if taking MK-2828 more than once affects how much midazolam is in the body after a single dose.
Eligibility
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
\- Participant is in good health
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
- History of cancer (malignancy)
- History of clinically significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases


